grant

The utility of PI3K inhibitors as adjuvant thrombolytic agents in ischaemic stroke and myocardial infarction [ 2010 - 2013 ]

Also known as: The benefit of novel antiplatelet drugs combined with clot busting drugs for the treatment of heart attack and stroke

Funded by National Health and Medical Research Council
Managed by Monash University
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/607231]

Researchers: Dr Zane Kaplan (Principal investigator)

Funding Amount $AUD 129,593.79

Funding Scheme NHMRC Postgraduate Scholarships

Notes Medical Postgraduate Scholarship

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Cardiorespiratory Medicine and Haematology | Cardiovascular Medicine and Haematology Not Elsewhere Classified | Medical and Health Sciences | kinases | myocardial infarction | platelet adhesion | platelet aggregation | stroke |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA
ACN 633 798 857